MDSCs exert potent suppression of CD8+ T-cell activity by employing the expression of Fas-ligand, which engages with Fas receptors on tumor-infiltrating lymphocytes (TILs), triggering the apoptotic demise of these critical immune cells and they are also involved in the recruitment of tumor-associated macrophages (11). The gene discussed is FASLG; the disease is neoplasm.